Xofluza 2 mg / mL granules for oral suspension

Licence status
Authorised: 07/01/2021
Active substances
Baloxavir Marboxil
Dosage Form
Granules for oral suspension
Licence number
EU/1/20/1500/005
Licence holder
Roche Registration GmbH

Product documents

Licence information

ATC code
J05AX25 baloxavir marboxil
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
07/01/2021